Aberdeen Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.6M | Buy |
795,584
+15,793
| +2% | +$1.1M | 0.09% | 188 |
|
|
2025
Q1 | $57.3M | Sell |
779,791
-621,698
| -44% | -$45.7M | 0.11% | 170 |
|
|
2024
Q4 | $91.8M | Buy |
1,401,489
+39,173
| +3% | +$2.57M | 0.17% | 123 |
|
|
2024
Q3 | $106M | Sell |
1,362,316
-144,207
| -10% | -$11.2M | 0.19% | 119 |
|
|
2024
Q2 | $117M | Buy |
1,506,523
+10,447
| +0.7% | +$815K | 0.23% | 101 |
|
|
2024
Q1 | $101M | Buy |
1,496,076
+75,200
| +5% | +$5.09M | 0.2% | 118 |
|
|
2023
Q4 | $95.7M | Buy |
1,420,876
+1,102,490
| +346% | +$74.3M | 0.21% | 112 |
|
|
2023
Q3 | $21.6M | Buy |
318,386
+1,600
| +0.5% | +$108K | 0.06% | 313 |
|
|
2023
Q2 | $22.7M | Sell |
316,786
-1,000
| -0.3% | -$71.6K | 0.05% | 318 |
|
|
2023
Q1 | $22.1M | Buy |
317,786
+20,900
| +7% | +$1.45M | 0.06% | 323 |
|
|
2022
Q4 | $20.1M | Hold |
296,886
| – | – | 0.05% | 331 |
|
|
2022
Q3 | $16.3M | Hold |
296,886
| – | – | 0.05% | 350 |
|
|
2022
Q2 | $19.6M | Sell |
296,886
-29,709
| -9% | -$1.96M | 0.06% | 291 |
|
|
2022
Q1 | $21.7M | Sell |
326,595
-38,800
| -11% | -$2.57M | 0.06% | 294 |
|
|
2021
Q4 | $21.3M | Sell |
365,395
-30,500
| -8% | -$1.78M | 0.05% | 328 |
|
|
2021
Q3 | $23.8M | Buy |
395,895
+24,640
| +7% | +$1.48M | 0.05% | 315 |
|
|
2021
Q2 | $22.2M | Buy |
371,255
+11,300
| +3% | +$677K | 0.05% | 338 |
|
|
2021
Q1 | $17.9M | Buy |
359,955
+1,200
| +0.3% | +$59.7K | 0.04% | 363 |
|
|
2020
Q4 | $17.9M | Buy |
358,755
+89,055
| +33% | +$4.45M | 0.04% | 343 |
|
|
2020
Q3 | $14.8M | Sell |
269,700
-1,800
| -0.7% | -$98.7K | 0.04% | 341 |
|
|
2020
Q2 | $14.4M | Hold |
271,500
| – | – | 0.04% | 345 |
|
|
2020
Q1 | $12.1M | Buy |
+271,500
| New | +$12.1M | 0.04% | 358 |
|